Trimel to Present at the 2014 Bloom Burton & Co. Healthcare Investor Conference
16 Junho 2014 - 4:20PM
Marketwired
Trimel to Present at the 2014 Bloom Burton & Co. Healthcare
Investor Conference
TORONTO, ONTARIO--(Marketwired - Jun 16, 2014) - Trimel
Pharmaceuticals Corporation (TSX:TRL) today announced that
management is scheduled to present an overview of the Company at
the 2014 Bloom Burton & Co. Healthcare Investor Conference at
the Toronto Board of Trade on June 18th, 2014 at 2:30 p.m. (Eastern
time). The presentation materials will also be made available on
the Trimel website at www.trimelpharmaceuticals.com.
About Trimel
Trimel is a specialty pharmaceutical company actively developing
medications for male hypogonadism, female sexual dysfunction and
various respiratory disorders. Natesto™, a product utilizing
Trimel's licensed bioadhesive nasal gel technology, has been
approved for sale in the United States by the FDA. For more
information, please visit www.trimelpharmaceuticals.com.
Trimel Pharmaceuticals CorporationKenneth HowlingChief Financial
Officer(416)
679-0536ir@trimelpharmaceuticals.comwww.trimelpharmaceuticals.com
Trilogy International Pa... (TSX:TRL)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Trilogy International Pa... (TSX:TRL)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024
Notícias em tempo-real sobre Trilogy International Partners Inc da Toronto Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Trimel Pharmaceuticals Corp